BridgeMD
New treatment option for Idiopathic Pulmonary Fibrosis (IPF)
Official title Downhill Walking in IPF
ClinicalTrials.gov ID: NCT06756230
What this study is testing
- What it's testing
- In this study; will examine the effects of downhill walking (eccentric exercise training) on exercise capacity, quality of life, and blood lactate levels in individuals with IPF. After the initial assessment, patients will be randomized into two groups: downhill walking PR group and Standard PR Group.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- Having a diagnosis of IPF according to the clinical diagnostic criteria of the American Thoracic Society and/or the European Respiratory Society...
- Being between the ages of 18 and 75.
- Being able to walk on a treadmill.
- Having the ability to cooperate.
- No change in current medication in the last month.
You likely can't join if
- Presence of physical or mental impairment that prevents informed consent or compliance with the protocol.
- Inability to attend more than 20% of pulmonary rehabilitation sessions.
- Presence of major cardiovascular disease (coronary artery disease, uncontrolled hypertension, arrhythmias, or heart failure).
- Presence of existing orthopedic and neuromuscular exercise limitations.
- Acute exacerbation
See the full eligibility criteria
- Having a diagnosis of IPF according to the clinical diagnostic criteria of the American Thoracic Society and/or the European Respiratory Society (ATS-ERS).
- Being between the ages of 18 and 75.
- Being able to walk on a treadmill.
- Having the ability to cooperate.
- No change in current medication in the last month.
- Not participating in a structured activity program for at least six months.
- Accepting the purpose and method of this study voluntarily and give informed consent for the study.
- Presence of physical or mental impairment that prevents informed consent or compliance with the protocol.
- Inability to attend more than 20% of pulmonary rehabilitation sessions.
- Presence of major cardiovascular disease (coronary artery disease, uncontrolled hypertension, arrhythmias, or heart failure).
- Presence of existing orthopedic and neuromuscular exercise limitations.
- Acute exacerbation
The study team makes the final eligibility decision.
Where it's taking place
- Istanbul, Üsküdar, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Istanbul, Üsküdar, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.